Chronic Kidney Disease News

In patients with heart failure and mildly reduced or preserved ejection fraction, finerenone improved outcomes compared with placebo regardless of baseline diabetes status, according to new data from the FINEARTS-HF trial.

Findings from an observational cohort study suggest a link between how soon someone begins to smoke after waking up each day and risk for chronic kidney disease.

Older adults with end-stage kidney disease had “modest gains” in life expectancy by starting on dialysis vs. choosing continuing medical management but spent less time at home, results from study show.

A clinical scale was validated for early detection of infections at the exit site of central venous catheters for hemodialysis in patients with kidney disease, according to a study.

The National Kidney Foundation launched a new interactive portal that lets patients with chronic kidney disease learn more about their condition, according to a press release.

The FDA granted full approval to Filspari, a daily oral, non-immunosuppressive medication, to slow kidney function decline in adults with primary IgA nephropathy, according to an industry press release.

During a 20-year period, patients with end-stage kidney disease treated with hemodialysis saw a reduction in mortality worldwide, study results show. The biggest gain in survival was among patients the United States.

Canagliflozin may reduce albuminuria and patient-specific eGFR decline in patients with type 2 diabetes and microalbuminuria, researchers found in a parallel, open-labeled trial.

Automated peritoneal dialysis may be linked to fewer dialysis-related complications and lower initial hospitalization costs compared with hemodialysis for certain patients, according to published data.

Allopurinol and febuxostat were both associated with lower all-cause mortality when used by adults undergoing hemodialysis in Japan; allopurinol also lowered risk of death from CVD events, according to study data.